Diagnos: Using AI to Analyze the Retina
Diagnos is an AI company. They have been a leader in artificial intelligence and healthcare technical services since 2001. Their company mission is to …
Starting clinical trials with the second largest hospital group in the U.S.
Diagnos is an AI company. They have been a leader in artificial intelligence and healthcare technical services since 2001. Their company mission is to develop AI tools to assist healthcare professionals in the detection of critical health issues.
Further, they have a team with over 50 years of combined experience working on artificial intelligence. They employ experts in the fields of healthcare, various scientists, and technical experts with advanced academic degrees.
Cara
They have a product called Cara used for computer-assisted retinal analyses. What this product does is automatically analyze the retina, and it can spot damage caused by diabetes or cardiovascular issues. That said, Cara can actually save someone from going blind.
"I think we can actually prove to the world that what we do is sustainable and that we're going to grow." - CEO, André Larente.
For more information on Diagnos (TSX.V: ADK) please click the request investor info button.
Latest Articles
Hot Companies
You might also like
BTV Showcases Contango Ore, Critical Elements Lithium, Dryden Gold, FireFox Gold, Kirkland Lake, Klondike Gold, and Selkirk Mines
This week, BTV - Business Television we feature growth-focused mining companies advancing major projects across North America and Europe. From emerging producers and strategic combinations to high-grade exploration and critical mineral development, this episode highlights the next wave of opportunity in the resource sector, including:
Selkirk Copper: A Yukon restart positioned to deliver new Canadian copper supply by 2028
A 50,000-metre drill program began last summer to expand understanding of the resource and guide updated mine design. The goal is to define a 12–15 year mine life while refreshing permits and engineering.
